A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors

Clinical trial NCT07343453 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07343453
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Thymic Epithelial Tumors Advanced Stage Second-line Therapy

Start date: 2025-12-22
Primary completion: 2027-12-22
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.